Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Killock

Showing results (211-220 of 304) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|February 27, 2023
CAR T cells show superiority over standard therapies for RRMMDavid Killock
Nature Reviews. Clinical Oncology|August 6, 2020
CAR T cells are active in Hodgkin lymphomaDavid Killock
Nature Reviews. Urology|June 11, 2014
Surgery: retroperitoneoscopic partial nephrectomy: practice is keyDavid Killock
Nature Reviews. Urology|July 2, 2014
Infectious disease: New Trichs: screening and therapyDavid Killock
Nature Reviews. Clinical Oncology|October 29, 2025
Frontline sacituzumab govitecan prolongs PFS in TNBCDavid Killock
Nature Reviews. Clinical Oncology|May 5, 2023
HSCT prolongs remission of high-risk CTCLsDavid Killock
Nature Reviews. Clinical Oncology|April 27, 2023
Biliary tract cancer: frontline pembrolizumab hits KEYNOTEDavid Killock
Nature Reviews. Clinical Oncology|July 1, 2022
AKT inhibition associated with improved OSDavid Killock
Nature Reviews. Clinical Oncology|January 31, 2020
Dasatinib versus imatinib in paediatric ALLDavid Killock
Nature Reviews. Clinical Oncology|June 22, 2021
KTE-X19 efficacious in adults with B-ALLDavid Killock
Pageof 31

Showing results (211-220 of 304) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|February 27, 2023
CAR T cells show superiority over standard therapies for RRMMDavid Killock
Nature Reviews. Clinical Oncology|August 6, 2020
CAR T cells are active in Hodgkin lymphomaDavid Killock
Nature Reviews. Urology|June 11, 2014
Surgery: retroperitoneoscopic partial nephrectomy: practice is keyDavid Killock
Nature Reviews. Urology|July 2, 2014
Infectious disease: New Trichs: screening and therapyDavid Killock
Nature Reviews. Clinical Oncology|October 29, 2025
Frontline sacituzumab govitecan prolongs PFS in TNBCDavid Killock
Nature Reviews. Clinical Oncology|May 5, 2023
HSCT prolongs remission of high-risk CTCLsDavid Killock
Nature Reviews. Clinical Oncology|April 27, 2023
Biliary tract cancer: frontline pembrolizumab hits KEYNOTEDavid Killock
Nature Reviews. Clinical Oncology|July 1, 2022
AKT inhibition associated with improved OSDavid Killock
Nature Reviews. Clinical Oncology|January 31, 2020
Dasatinib versus imatinib in paediatric ALLDavid Killock
Nature Reviews. Clinical Oncology|June 22, 2021
KTE-X19 efficacious in adults with B-ALLDavid Killock
Pageof 31